Hana Biosciences To Present At Healthcare Conference

November 27, 2009 (FinancialWire) — Hana Biosciences (OTCBB: HNAB), a biopharmaceutical company focused on strengthening the foundation of cancer care, announced that Steven R. Deitcher, M.D., president and chief executive officer, will present an overview of the company at the 21st Annual Piper Jaffray Healthcare Conference on Wednesday, December 2, 2009, at 8: 00 a.m. eastern time.

The conference is being held December 1-2, 2009, in New York City at The New York Palace.

A live audio webcast will be available in the Investor Relations section of Hana’s website at www.hanabiosciences.com. An archived replay of the webcast will be available for 10 business days following the presentation.

Hana Biosciences, Inc. is a biopharmaceutical company dedicated to developing and commercializing new, differentiated cancer therapies designed to improve and enable current standards of care.

FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation for its news, opinions or distributions. Further disclosure is at the FinancialWire(tm) web site (http://www.financialwire.net/disclosures.php). Contact FinancialWire(tm) directly via inquiries@financialwire.net.

Free annual reports for companies mentioned in the news are available through the Free Annual Reports Service (http://investrend.ar.wilink.com/?level=279).

Powered by EIN Presswire